• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

    IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

    /DISREGARD RELEASE: M4Markets/

    GENAI Summit 2025: Forging a Network of AI Innovators

    GENAI Summit 2025: Forging a Network of AI Innovators

    New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

    New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

    Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial

    Sale of Green Form flats announced

    Sale of Green Form flats announced

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

    IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

    /DISREGARD RELEASE: M4Markets/

    GENAI Summit 2025: Forging a Network of AI Innovators

    GENAI Summit 2025: Forging a Network of AI Innovators

    New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

    New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

    Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Regimen achieving >50% Reduction in Circulating Tumor Cells in Phase 1b Trial

    Sale of Green Form flats announced

    Sale of Green Form flats announced

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

Cohesity Automation Provides Faster, More Comprehensive Cyber Incident Response

PR Newswire by PR Newswire
23 April 2025
in PR Newswire
0
Cohesity Automation Provides Faster, More Comprehensive Cyber Incident Response
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Cohesity RecoveryAgent’s AI-powered Orchestration Makes Cyber Response and Recovery Easy so Customers Can Recover From Incidents Faster and With More Confidence 

SINGAPORE, April 23, 2025 /PRNewswire/ — Cohesity, the leader in AI-powered data security, today announced Cohesity RecoveryAgent, a new AI-powered cyber orchestration solution for Cohesity NetBackup and DataProtect customers. RecoveryAgent automates cyber recovery preparation, testing, compliance, and response, enabling customers to recover from cyber incidents faster. It offers intelligent, customizable recovery blueprints and enables rigorous testing of recovery processes in a non-production environment, giving customers more confidence in their ability to respond to proliferating cyberattacks.

Simplifying Cyber Recovery Through Automation and Intelligence
Modern IT environments are complex, comprising physical, virtual, and cloud-based systems. Responding to cyberattacks requires organizations to navigate this complexity while ensuring data integrity, availability, and regulatory compliance. RecoveryAgent addresses these challenges by generating customizable blueprints that automate recovery workflows, making cyber recovery response more efficient and adaptable.

With these customizable blueprints, organizations can better prepare for cyber incidents before they happen. RecoveryAgent’s intuitive UI allows teams to easily build recovery plans with scripted workflows that automatically integrate critical steps for incident response, such as threat hunting, malware scanning, and instant data restores. Users can rehearse recoveries to prove the blueprint will effectively recover their data in a non-production environment without impacting production applications. This frequent testing helps ensure readiness for real-world incidents.

RecoveryAgent’s Agentic AI capabilities allow recovery teams to:

  • Rapidly and easily create and edit recovery blueprints with AI assistance for automated testing of cyber impact or disaster recovery
  • Manage granular recovery across multiple domains in complex hybrid environments, including on-premises, cloud, PaaS, and containers
  • Speed up forensic investigations through automated threat scanning using native tools and best-in-class threat intelligence from Data Security Alliance partners
  • Have more confidence in a clean incident recovery with Agentic AI-powered intelligent recovery point recommendations and blast radius analysis of infected files across domains
  • Understand the real-world recovery times and how they align with the business SLAs
  • Ensure and demonstrate compliance with regulatory and business drivers by implementing standard recovery practices

“Every moment matters to customers experiencing a cyber incident. Having a comprehensive and thoroughly tested incident response plan can be the difference between minimal disruption and massive impact,” said Vasu Murthy, Chief Product Officer, Cohesity. “By simplifying and automating every step of the complex cyber recovery process, RecoveryAgent helps customers boost resilience and respond faster with more confidence to cyber incidents. The world’s largest organizations trust Cohesity because we understand the impact of cyber incidents and consistently offer new solutions like RecoveryAgent to help our customers be more confident in their cyber readiness and recovery.”

Seamless Integration for Enhanced Cyber Resilience
RecoveryAgent automates time-consuming and manual tasks such as vulnerability scanning, malware scanning, and data classification into a structured blueprint. It can also automate forensics investigation, configuration hardening, and patching when orchestrated on virtual machines that are recovered within the solution. These capabilities are powered by Cohesity’s Data Security Alliance, which integrates with leading security vendors to help security teams become more agile and productive. Additionally, RecoveryAgent enhances Cohesity’s existing clean room solution, making activation faster and more intuitive.  

“AntemetA has a complex technology infrastructure, and as a result, we need solutions developed with extensive field experience to enable us to be as effective as possible, especially as we are exposed to increasing amount of cyber risks,” said Stéphane Colin, CTO, AntemetA. “This is only possible with trusted partners who take time to understand our unique complexity and work with us to ensure our data can be recovered with confidence and our services guarantee the highest level of resilience, whatever cyber challenges we face. We have a longstanding partnership with Cohesity because it continues to develop solutions like RecoveryAgent, which help us deliver more relevant and effective services. That, in turn, has earned us an equally long-lasting trust from our customers.”

RecoveryAgent is the first new offering to emerge from the joint development efforts of Cohesity and Veritas since the companies came together in December. By combining the capabilities of NetBackup Recovery Blueprints and Recommended Recovery Points with AI-powered intelligence and innovation native to DataProtect, RecoveryAgent is an example of the rapid innovation enabled by integrating both companies’ technology. It also highlights Cohesity’s commitment to simplifying user experiences and enhancing customer confidence in cyber resilience strategies.

RecoveryAgent is currently available to select customers in Tech Preview and is expected to be generally available for NetBackup and DataProtect customers in the second half of the calendar year 2025.

For more information about Cohesity RecoveryAgent and how it can support your organization’s cybersecurity needs, watch our video. And for more insights on breach response and how to strengthen your organization’s resilience, watch our conversation.    

About Cohesity

Cohesity is the leader in AI-powered data security. Over 13,600 enterprise customers, including over 85 of the Fortune 100 and nearly 70% of the Global 500, rely on Cohesity to strengthen their resilience while providing Gen AI insights into their vast amounts of data. Formed from the combination of Cohesity with Veritas’ enterprise data protection business, the company’s solutions secure and protect data on-premises, in the cloud, and at the edge. Backed by NVIDIA, IBM, HPE, Cisco, AWS, Google Cloud, and others, Cohesity is headquartered in Santa Clara, CA, with offices around the globe. To learn more, follow Cohesity on LinkedIn, X, and Facebook.

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

9 July 2025

/DISREGARD RELEASE: M4Markets/

9 July 2025
  • Trending
  • Comments
  • Latest
Hasten Accelerates Asia-Pacific Expansion with Successful MAT Transfers of 11 Products

Hasten Accelerates Asia-Pacific Expansion with Successful MAT Transfers of 11 Products

16 June 2025

Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

16 June 2025
Southbound travel plan announced

Southbound travel plan announced

2 July 2025
FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

17 June 2025
IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

9 July 2025

/DISREGARD RELEASE: M4Markets/

9 July 2025
GENAI Summit 2025: Forging a Network of AI Innovators

GENAI Summit 2025: Forging a Network of AI Innovators

9 July 2025
New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

9 July 2025

Recent News

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

9 July 2025

/DISREGARD RELEASE: M4Markets/

9 July 2025
GENAI Summit 2025: Forging a Network of AI Innovators

GENAI Summit 2025: Forging a Network of AI Innovators

9 July 2025
New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

New DJI Power 1000 V2 Increases Stable Power Output for a Smarter, More Efficient Experience

9 July 2025
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com